全文获取类型
收费全文 | 52938篇 |
免费 | 2985篇 |
国内免费 | 360篇 |
专业分类
耳鼻咽喉 | 156篇 |
儿科学 | 1207篇 |
妇产科学 | 693篇 |
基础医学 | 3620篇 |
口腔科学 | 777篇 |
临床医学 | 6932篇 |
内科学 | 5858篇 |
皮肤病学 | 413篇 |
神经病学 | 1964篇 |
特种医学 | 678篇 |
外科学 | 2433篇 |
综合类 | 7516篇 |
现状与发展 | 2篇 |
一般理论 | 8篇 |
预防医学 | 18641篇 |
眼科学 | 272篇 |
药学 | 2970篇 |
32篇 | |
中国医学 | 948篇 |
肿瘤学 | 1163篇 |
出版年
2023年 | 925篇 |
2022年 | 1630篇 |
2021年 | 2406篇 |
2020年 | 2405篇 |
2019年 | 3176篇 |
2018年 | 2783篇 |
2017年 | 1928篇 |
2016年 | 1461篇 |
2015年 | 1718篇 |
2014年 | 4074篇 |
2013年 | 3896篇 |
2012年 | 3592篇 |
2011年 | 3855篇 |
2010年 | 2978篇 |
2009年 | 2686篇 |
2008年 | 2704篇 |
2007年 | 2421篇 |
2006年 | 1923篇 |
2005年 | 1334篇 |
2004年 | 1072篇 |
2003年 | 882篇 |
2002年 | 665篇 |
2001年 | 544篇 |
2000年 | 474篇 |
1999年 | 381篇 |
1998年 | 320篇 |
1997年 | 241篇 |
1996年 | 140篇 |
1995年 | 149篇 |
1994年 | 118篇 |
1993年 | 109篇 |
1992年 | 97篇 |
1991年 | 82篇 |
1990年 | 44篇 |
1989年 | 46篇 |
1988年 | 43篇 |
1987年 | 42篇 |
1985年 | 266篇 |
1984年 | 378篇 |
1983年 | 317篇 |
1982年 | 315篇 |
1981年 | 304篇 |
1980年 | 250篇 |
1979年 | 236篇 |
1978年 | 210篇 |
1977年 | 154篇 |
1976年 | 137篇 |
1975年 | 121篇 |
1974年 | 103篇 |
1973年 | 78篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
《Patient education and counseling》2022,105(12):3398-3409
ObjectiveThis systematic review aimed to identify the information needs and preferences of individuals with CVD from underserved populations.MethodsFive databases were searched from data inception to February 2022. Pilot and case report studies, non-peer-reviewed literature, and studies published in a language other than English, Portuguese, or Spanish were excluded. Structured and thematic analysis of all included studies were performed. The Critical Appraisal Skills Program and the Downs and Black Checklist were used to assess the quality of the qualitative and quantitative studies, respectively.ResultsOf 35,698 initial records, 19 studies were included, most in observational design and classified as “fair” quality. Underserved populations – women, people living in rural areas, ethnic minority groups, older people, and those with low socioeconomic status – presented unique needs in four main groups, with some similarities across them: information about CVD, primary and secondary prevention of CVD, CVD management, and health care, policies and practices. Across the studies there was a lack of standardization on how individuals’ needs were assessed and reported.ConclusionUnderserved populations with CVD have unique information needs and preferences that should be address during their care.Practical implicationInformation from this study may assist health care professionals with the development of comprehensive strategies to improve their provision of care for specific CVD patient groups. 相似文献
102.
103.
104.
105.
106.
《Vaccine》2021,39(27):3544-3559
This report addresses the epidemiological aspects and feasibility of measles and rubella eradication and the potential resource requirements in response to the request of the Director-General at the Seventieth World Health Assembly held on May 31, 2017. A guiding principle is that the path toward measles and rubella eradication should serve to strengthen primary health care, promote universal health coverage, and be a pathfinder for new vision and strategy for immunization over the next decade as laid out in the Immunization Agenda 2030. Specifically, this report: 1) highlights the importance of measles and rubella as global health priorities; 2) reviews the current global measles and rubella situation; 3) summarizes prior assessments of the feasibility of measles and rubella eradication; 4) assesses the progress and challenges in achieving regional measles and rubella elimination; 5) assesses additional considerations for measles and rubella eradication, including the results of modelling and economic analyses; 6) assesses the implications of establishing a measles and rubella eradication goal and the process for setting an eradication target date; 7) proposes a framework for determining preconditions for setting a target date for measles and rubella eradication and how these preconditions should be understood and used; and 8) concludes with recommendations endorsed by SAGE. 相似文献
107.
《Gaceta sanitaria / S.E.S.P.A.S》2021,35(4):345-351
ObjectiveTo present part of the results of the evaluation of this strategy.MethodLongitudinal (pre-post) and quasi-experimental (experimental and control group) design, collecting information from 228 women (114 each group) in four moments (one month before the program; one month after the end of the program; six months and a year and a half). Among the instruments used are the Anxiety and Depression Scale and the Rosenberg Self-Esteem Scale.ResultsWomen in the experimental group reduce their symptoms of depression and anxiety and improve their self-esteem after participating in the program, and this improvement is maintained until a year and a half after the end of it. On the contrary, women in the control group do not present pre-post differences in almost none of the variables analyzed (except in anxiety symptoms).ConclusionThese results support GRUSE as a non-medical intervention, and it is considered that they can serve as a stimulus to maintain the strategy and even extend it to other population groups that also experience psychosocial discomfort. 相似文献
108.
《Vaccine》2021,39(34):4864-4870
Background and AimsInfluenza vaccination is recommended by the World Health Organisation for pregnant women, offering the dual benefit of protecting pregnant women and their newborn infants against influenza infection. Various factors can influence vaccine immunogenicity, with obesity being one factor implicated in varied responses. This study aimed to investigate the impact of body mass index (BMI) on vaccine responses following influenza vaccination during pregnancy.MethodsPregnant women attending the Women’s and Children’s Hospital in South Australia during 2014–2016 were invited to participate. Participant’s clinical and demographic factors were recorded prior to administration of licensed seasonal influenza vaccination. Blood samples were collected before and one month post-vaccination to measure antibody responses by haemagglutination inhibition (HI) assay. Seroprotection was defined as a post-vaccination HI titre ≥ 1:40. Regression models assessed associations with failure to achieve seroprotective antibodies to H1, H3, and B influenza strains.ResultsA total of 96 women were enrolled in the study at a median gestation of 22 weeks with a BMI range of 18–49 kg/m2. Paired sera samples were available for 90/96 (94%). Most pregnant women (72/90, 80%) demonstrated seroprotective antibody titres to all three influenza vaccine antigens (A(H1N1)pdm09, A(H3N2), B/Yamagata) following vaccination. Compared with women with BMI < 30 kg/m2, those with high BMI were less likely to fail to achieve seroprotective antibodies, however this was not statistically significant (RR 0.42, 95% CI 0.11–1.68; p = 0.22). A greater proportion of women vaccinated during their second (47/53, 93%) or third trimester (18/25, 72%) demonstrated seroprotection to all three vaccine antigens following vaccination compared with women vaccinated during their first trimester (7/12, 58%).ConclusionHigh BMI did not impair seroprotection levels following influenza vaccination in pregnant women. Gestation at vaccination may be an important consideration for optimising vaccine protection for pregnant women and their newborns. Further assessment of first trimester influenza vaccine responses is warranted. 相似文献
109.
110.
目的 本研究为探究丹参川芎嗪注射液治疗冠状动脉硬化性心脏病联合用药优效方案。通过全国19家三甲医院信息系统(hospital information system,HIS)数据库中优效人群联合用药规律探讨冠心病治疗中丹参川芎嗪联合用药方案。方法 全国19家三甲医院4952例患者纳入分析,采用真实世界研究方法及Tabu搜索算法。结果 丹参川芎嗪注射液 + 单硝酸异山梨酯 + 速效救心丸 + 阿卡波糖 + 蛋白水解物,为冠心病中西医联合用药频次最高组合,适宜冠心病心绞痛合并糖尿病及缺血性脑血管疾病患者;丹参川芎嗪注射液 + 维生素复方 + 蛋白水解物 + 硝酸甘油 + 头孢类 + 阿卡波糖为最常见西药搭配,用于冠心病合并消化性溃疡、失眠、炎症及糖尿病;活血化瘀制剂(化瘀通脉剂) + 益气养阴剂 + 清热类中药为使用频率最高组合用于冠心病血瘀证合并气阴两虚或阴虚火旺证。结论 目前临床治疗冠心病越来越关注全身治疗,符合中医整体观念及治未病原则。丹参川芎嗪注射液治疗冠心病联合用药符合最新的冠心病诊疗指南。 相似文献